GDNF administration induces recovery of the nigrostriatal dopaminergic system both in young and aged Parkinsonian mice

Isao Date; Mizuho Aoi; Susumu Tomita; Frank Collins; Takashi Ohmoto

doi:10.1097/00001756-199807130-00039

GDNF administration induces recovery of the nigrostriatal dopaminergic system both in young and aged Parkinsonian mice

Isao Date, Mizuho Aoi, Susumu Tomita, Frank Collins, Takashi Ohmoto

Research output: Contribution to journal › Article › peer-review

49 Citations (Scopus)

Abstract

Glial cell line-derived neurotrophic factor (GDNF) is a member of the transforming growth factor β super-family and acts as a neurotrophic factor for the nigrostriatal dopaminergic system. GDNF was injected stereotaxically into the striatum of young (2 months old) and aged (12 months old) C57BL/6 mice that were treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) 1 week earlier. Immunocytochemical and neurochemical analyses showed significant recovery of the nigrostriatal dopaminergic system both in young and in aged mice. Since Parkinson's disease is a neurodegenerative disorder mainly affecting elderly people, this result demonstrates the potential usefulness of GDNF in treating Parkinson's disease.

Original language	English
Pages (from-to)	2365-2369
Number of pages	5
Journal	NeuroReport
Volume	9
Issue number	10
DOIs	https://doi.org/10.1097/00001756-199807130-00039
Publication status	Published - Jul 13 1998

Keywords

Ageing
Dopamine
GDNF
Parkinson's disease

ASJC Scopus subject areas

Neuroscience(all)

Access to Document

10.1097/00001756-199807130-00039

Fingerprint Dive into the research topics of 'GDNF administration induces recovery of the nigrostriatal dopaminergic system both in young and aged Parkinsonian mice'. Together they form a unique fingerprint.

Cite this

@article{fc1f05bb271c43a987ff12f61ef54432,

title = "GDNF administration induces recovery of the nigrostriatal dopaminergic system both in young and aged Parkinsonian mice",

abstract = "Glial cell line-derived neurotrophic factor (GDNF) is a member of the transforming growth factor β super-family and acts as a neurotrophic factor for the nigrostriatal dopaminergic system. GDNF was injected stereotaxically into the striatum of young (2 months old) and aged (12 months old) C57BL/6 mice that were treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) 1 week earlier. Immunocytochemical and neurochemical analyses showed significant recovery of the nigrostriatal dopaminergic system both in young and in aged mice. Since Parkinson's disease is a neurodegenerative disorder mainly affecting elderly people, this result demonstrates the potential usefulness of GDNF in treating Parkinson's disease.",

keywords = "Ageing, Dopamine, GDNF, Parkinson's disease",

author = "Isao Date and Mizuho Aoi and Susumu Tomita and Frank Collins and Takashi Ohmoto",

year = "1998",

month = jul,

day = "13",

doi = "10.1097/00001756-199807130-00039",

language = "English",

volume = "9",

pages = "2365--2369",

journal = "NeuroReport",

issn = "0959-4965",

publisher = "Lippincott Williams and Wilkins",

number = "10",

}

TY - JOUR

T1 - GDNF administration induces recovery of the nigrostriatal dopaminergic system both in young and aged Parkinsonian mice

AU - Date, Isao

AU - Aoi, Mizuho

AU - Tomita, Susumu

AU - Collins, Frank

AU - Ohmoto, Takashi

PY - 1998/7/13

Y1 - 1998/7/13

N2 - Glial cell line-derived neurotrophic factor (GDNF) is a member of the transforming growth factor β super-family and acts as a neurotrophic factor for the nigrostriatal dopaminergic system. GDNF was injected stereotaxically into the striatum of young (2 months old) and aged (12 months old) C57BL/6 mice that were treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) 1 week earlier. Immunocytochemical and neurochemical analyses showed significant recovery of the nigrostriatal dopaminergic system both in young and in aged mice. Since Parkinson's disease is a neurodegenerative disorder mainly affecting elderly people, this result demonstrates the potential usefulness of GDNF in treating Parkinson's disease.

AB - Glial cell line-derived neurotrophic factor (GDNF) is a member of the transforming growth factor β super-family and acts as a neurotrophic factor for the nigrostriatal dopaminergic system. GDNF was injected stereotaxically into the striatum of young (2 months old) and aged (12 months old) C57BL/6 mice that were treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) 1 week earlier. Immunocytochemical and neurochemical analyses showed significant recovery of the nigrostriatal dopaminergic system both in young and in aged mice. Since Parkinson's disease is a neurodegenerative disorder mainly affecting elderly people, this result demonstrates the potential usefulness of GDNF in treating Parkinson's disease.

KW - Ageing

KW - Dopamine

KW - GDNF

KW - Parkinson's disease

UR - http://www.scopus.com/inward/record.url?scp=0032514206&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032514206&partnerID=8YFLogxK

U2 - 10.1097/00001756-199807130-00039

DO - 10.1097/00001756-199807130-00039

M3 - Article

C2 - 9694229

AN - SCOPUS:0032514206

VL - 9

SP - 2365

EP - 2369

JO - NeuroReport

JF - NeuroReport

SN - 0959-4965

IS - 10

ER -